Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data

Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data

•In patients treated with deferiprone, ANC levels

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood advances 2024-11, Vol.8 (21), p.5641-5649
Hauptverfasser: Badawy, Sherif M., Palmblad, Jan, Tricta, Fernando, Toiber Temin, Noemi, Fradette, Caroline, Lin, Leo, Rozova, Anna, Sheth, Sujit
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Deferiprone - adverse effects
Deferiprone - therapeutic use
Female
Humans
Infections - etiology
Iron Chelating Agents - adverse effects
Iron Chelating Agents - therapeutic use
Iron Overload - drug therapy
Iron Overload - etiology
Male
Neutropenia - chemically induced
Pyridones - adverse effects
Pyridones - therapeutic use
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•In patients treated with deferiprone, ANC levels
ISSN:2473-9529
2473-9537
2473-9537
DOI:10.1182/bloodadvances.2023012316